跳至主要内容
临床试验/NCT01167140
NCT01167140已完成2 期

Cryo-Touch II for the Treatment of Wrinkles

Pacira Pharmaceuticals, Inc1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2010年7月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
42
试验地点
1
主要终点
Number of Participants With Effectiveness and Safety Success

研究概览

简要总结

This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch II device for the treatment of wrinkles.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 30-70 years
  • •Subject has a glabellar and/or forehead wrinkle rating by investigator of at least 1 at rest on the 5-point Wrinkle Scale (5WS)*
  • •Subject has signed IRB-approved informed consent form

排除标准

  • •Subject takes any medication or dietary supplement regularly that affects blood clotting (e.g., Coumadin, aspirin, clopidogrel) or increases the risk of bleeding/bruising
  • •Subject has had prior surgery that alters the subcutaneous anatomy of the target treatment sites
  • •The investigator is unable to substantially lessen facial lines by physical separation
  • •Subject has undergone another facial cosmetic procedures at or above the level of the cheekbones within the past 6 months
  • •Subject is participating in another facial cosmetic research study
  • •Patient has any of following conditions:
  • •History of facial nerve palsy
  • •Marked facial asymmetry
  • •Excessive dermatochalasis
  • •Deep dermal scarring
  • •Thick sebaceous skin
  • •History of neuromuscular disorder
  • •Chronic dry eye symptoms
  • •Allergy or intolerance to lidocaine

研究组 & 干预措施

Cryo-Touch II

Experimental

干预措施: Cryo-Touch II (Device)

结局指标

主要结局

Number of Participants With Effectiveness and Safety Success

时间窗: Up to 4 months

* Effectiveness success: an improvement in line severity in the target area in animation at 30 days post-treatment as rated by the investigator using the 5-point wrinkle scale * Safety success: the absence of a device-related serious adverse event (DSAE)

次要结局

  • Participants With One Point Improvement in Line Severity(Baseline and up to 4 months)
  • Participants With an Improvement in Global Appearance(Up to 4 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验